SODIUM IODIDE I 123 Drug Patent Profile
✉ Email this page to a colleague
When do Sodium Iodide I 123 patents expire, and when can generic versions of Sodium Iodide I 123 launch?
Sodium Iodide I 123 is a drug marketed by Cardinal Health 418, Curium, and Ge Healthcare. and is included in four NDAs.
The generic ingredient in SODIUM IODIDE I 123 is sodium iodide i-123. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-123 profile page.
Summary for SODIUM IODIDE I 123
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 4 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 6 |
| Clinical Trials: | 17 |
| Patent Applications: | 10 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in SODIUM IODIDE I 123? | SODIUM IODIDE I 123 excipients list |
| DailyMed Link: | SODIUM IODIDE I 123 at DailyMed |
Recent Clinical Trials for SODIUM IODIDE I 123
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Osaka University | Phase 1 |
| AHS Cancer Control Alberta | Phase 1 |
| Alberta Cancer Foundation | Phase 1 |
US Patents and Regulatory Information for SODIUM IODIDE I 123
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cardinal Health 418 | SODIUM IODIDE I 123 | sodium iodide i-123 | CAPSULE;ORAL | 018671-001 | May 27, 1982 | AA | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Ge Healthcare | SODIUM IODIDE I 123 | sodium iodide i-123 | CAPSULE;ORAL | 017630-003 | Jan 8, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Curium | SODIUM IODIDE I 123 | sodium iodide i-123 | CAPSULE;ORAL | 071909-001 | Feb 28, 1989 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Ge Healthcare | SODIUM IODIDE I 123 | sodium iodide i-123 | SOLUTION;ORAL | 017630-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Cardinal Health 418 | SODIUM IODIDE I 123 | sodium iodide i-123 | CAPSULE;ORAL | 018671-002 | May 27, 1982 | AA | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Cardinal Health 418 | SODIUM IODIDE I 123 | sodium iodide i-123 | CAPSULE;ORAL | 018671-003 | May 27, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
